日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines

用于生产稳定病毒样颗粒作为下一代脊髓灰质炎疫苗的重组表达系统

Lee Sherry #, Mohammad W Bahar #, Claudine Porta #, Helen Fox #, Keith Grehan, Veronica Nasta, Helen M E Duyvesteyn, Luigi De Colibus, Johanna Marsian, Inga Murdoch, Daniel Ponndorf, Seong-Ryong Kim, Sachin Shah, Sarah Carlyle, Jessica J Swanson, Sue Matthews, Clare Nicol, George P Lomonossoff, Andr

Protease-Independent Production of Poliovirus Virus-like Particles in Pichia pastoris: Implications for Efficient Vaccine Development and Insights into Capsid Assembly

毕赤酵母中不依赖蛋白酶产生脊髓灰质炎病毒样颗粒:对高效疫苗开发的意义以及对衣壳组装的见解

Lee Sherry, Jessica J Swanson, Keith Grehan, Huijun Xu, Mai Uchida, Ian M Jones, Nicola J Stonehouse, David J Rowlands

A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation

脊髓灰质炎病毒中保守的谷胱甘肽结合位点是抗病毒药物和疫苗稳定的目标

Mohammad W Bahar, Veronica Nasta, Helen Fox, Lee Sherry, Keith Grehan, Claudine Porta, Andrew J Macadam, Nicola J Stonehouse, David J Rowlands, Elizabeth E Fry, David I Stuart

ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice

基于 ChAdOx1 和 MVA 的 MERS-CoV 候选疫苗在小鼠中引发中和抗体和细胞免疫反应

Naif Khalaf Alharbi, Eriko Padron-Regalado, Craig P Thompson, Alexandra Kupke, Daniel Wells, Megan A Sloan, Keith Grehan, Nigel Temperton, Teresa Lambe, George Warimwe, Stephan Becker, Adrian V S Hill, Sarah C Gilbert

An Optimized Method for the Production Using PEI, Titration and Neutralizationof SARS-CoV Spike Luciferase Pseudotypes

一种优化的利用 PEI 进行 SARS-CoV 刺突荧光素酶假型生产、滴定和中和的方法

George Carnell, Keith Grehan, Francesca Ferrara, Eleonora Molesti, Nigel Temperton